IQVIA Holdings Inc. has announced a strategic partnership with NVIDIA to develop custom foundation models and agentic AI workflows aimed at accelerating research, clinical development, and access to new treatments in the life sciences sector. This collaboration will leverage IQVIA's vast healthcare-specific data alongside NVIDIA's advanced technology to enhance and streamline clinical trials and commercial launches through powerful workflow coordination and insights. The new AI agents, unveiled at GTC Paris, are designed to transform business processes and improve patient outcomes by using NVIDIA's NIM Agent Blueprints, NeMo Customizer, and NeMo Guardrails for rapid development and secure deployment. This partnership highlights a pivotal opportunity for both companies to push the frontier of AI in healthcare, promising smarter solutions for the industry.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。